Novavax Inc (NVAX)
8.08
+0.02
(+0.25%)
USD |
NASDAQ |
Nov 21, 12:39
Novavax Market Cap: 1.294B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.291B |
| November 19, 2024 | 1.281B |
| November 18, 2024 | 1.254B |
| November 15, 2024 | 1.173B |
| November 14, 2024 | 1.157B |
| November 13, 2024 | 1.244B |
| November 12, 2024 | 1.355B |
| November 11, 2024 | 1.443B |
| November 08, 2024 | 1.427B |
| November 07, 2024 | 1.470B |
| November 06, 2024 | 1.435B |
| November 05, 2024 | 1.512B |
| November 04, 2024 | 1.461B |
| November 01, 2024 | 1.498B |
| October 31, 2024 | 1.539B |
| October 30, 2024 | 1.576B |
| October 29, 2024 | 1.613B |
| October 28, 2024 | 1.642B |
| October 25, 2024 | 1.561B |
| October 24, 2024 | 1.589B |
| October 23, 2024 | 1.601B |
| October 22, 2024 | 1.621B |
| October 21, 2024 | 1.624B |
| October 18, 2024 | 1.630B |
| October 17, 2024 | 1.658B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.626B |
| October 15, 2024 | 2.018B |
| October 14, 2024 | 2.021B |
| October 11, 2024 | 2.007B |
| October 10, 2024 | 2.067B |
| October 09, 2024 | 2.031B |
| October 08, 2024 | 2.088B |
| October 07, 2024 | 2.085B |
| October 04, 2024 | 2.180B |
| October 03, 2024 | 2.309B |
| October 02, 2024 | 2.351B |
| October 01, 2024 | 1.973B |
| September 30, 2024 | 2.023B |
| September 27, 2024 | 2.129B |
| September 26, 2024 | 1.944B |
| September 25, 2024 | 1.928B |
| September 24, 2024 | 2.128B |
| September 23, 2024 | 2.049B |
| September 20, 2024 | 2.067B |
| September 19, 2024 | 2.004B |
| September 18, 2024 | 2.011B |
| September 17, 2024 | 2.070B |
| September 16, 2024 | 2.113B |
| September 13, 2024 | 2.179B |
| September 12, 2024 | 1.908B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
99.67M
Minimum
Nov 26 2019
22.99B
Maximum
Feb 08 2021
4.911B
Average
2.129B
Median
Sep 27 2024
Market Cap Benchmarks
| Pfizer Inc | 141.62B |
| Moderna Inc | 14.27B |
| Inovio Pharmaceuticals Inc | 109.10M |
| Baxter International Inc | 16.85B |
| Halozyme Therapeutics Inc | 5.766B |
Market Cap Related Metrics
| PS Ratio | 1.406 |
| Price | 8.08 |
| Earnings Yield | -28.34% |